These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 560692)

  • 1. ["Immuno-allergic" complications of rifampicin therapy].
    Bessot JC; Vandevenne A; Petitjean R; Burghard G
    Poumon Coeur; 1977; 33(2):107-15. PubMed ID: 560692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Renal complications after rifampicin].
    Mănescu N; Dumitru S; Gluhovschi G; Golea O; Nicolcioiu M; Schwarzkopf A; Bercovici L; Hoţa F; Hoborca A; Zosin C
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1975; 24(1):35-42. PubMed ID: 171721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recurrent hemolytic accidents of immuno-allergic origin during intermittent treatment with rifampicin].
    Sors C; Sarrazin A; Homberg JC
    Rev Tuberc Pneumol (Paris); 1972; 36(3):405-16. PubMed ID: 5080967
    [No Abstract]   [Full Text] [Related]  

  • 4. [Daily and intermittent regimens using ethambutol and rifampicin in the treatment of unresponsive cases. (Evaluation after 1 year.) II. Side effects].
    Girling DJ
    Bull Int Union Tuberc; 1974; 49(1):451-5. PubMed ID: 4619567
    [No Abstract]   [Full Text] [Related]  

  • 5. [2 cases of hemolytic complications during intermittent treatment with rifampicin].
    Năstase M; Brener E; Năstase R; Borgovan L
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1975; 24(1):43-6. PubMed ID: 171722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Thrombocytopenia caused by hypersensitivity to rifampicin in intermittent high doses].
    Sepúlveda R; Soerensen R; Santiviago C; Alvarez R; Gay O; Zúñiga E; Meléndez M; Farga V
    Rev Med Chil; 1971 Dec; 99(12):934-8. PubMed ID: 5168230
    [No Abstract]   [Full Text] [Related]  

  • 7. Rifampicin-dependent antibodies in twice-weekly treated patients.
    Algeorge G; Rudescu D; Alexandrescu D
    Scand J Respir Dis Suppl; 1973; 84():98-101. PubMed ID: 4522081
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical aspects of side effects on intermittent rifampicin regimen.
    Zierski M
    Scand J Respir Dis Suppl; 1973; 84():166-73. PubMed ID: 4522072
    [No Abstract]   [Full Text] [Related]  

  • 9. [Letter: Immunoallergic thrombopenic purpura due to rifampicin].
    Devred C; Bernadou A; Bilski-Pasquier G; Marcelli A
    Nouv Presse Med; 1975 Aug 30-Sep 6; 4(28):2042. PubMed ID: 1237127
    [No Abstract]   [Full Text] [Related]  

  • 10. [Presence of antibodies against rifampicin in patients under tuberculostatic treatment].
    Ion N; Jemma I; Sfetcu V
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1981; 30(1):39-42. PubMed ID: 6264569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute renal failure after rifampicin therapy.
    Seufert CD
    Scand J Respir Dis Suppl; 1973; 84():174-9. PubMed ID: 4522073
    [No Abstract]   [Full Text] [Related]  

  • 12. Haematological changes during intermittent treatment with rifampicin.
    Wislawska-Orlowska B; Pniewski T
    Scand J Respir Dis Suppl; 1973; 84():94-7. PubMed ID: 4522080
    [No Abstract]   [Full Text] [Related]  

  • 13. The intermittent chemotherapy of tuberculosis with rifampicin regimens on ambulatory basis.
    Anastasatu C; Bungeteanu G; Sibila S
    Scand J Respir Dis Suppl; 1973; 84():136-9. PubMed ID: 4522068
    [No Abstract]   [Full Text] [Related]  

  • 14. Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazid for primary treatment: the influence of various factors on the frequency of side-effects.
    Eule H; Werner E; Winsel K; Iwainsky H
    Tubercle; 1974 Mar; 55(1):81-9. PubMed ID: 4620295
    [No Abstract]   [Full Text] [Related]  

  • 15. A controlled clinical trial of small daily doses of rifampicin in the prevention of adverse reactions to the drug in a once-weekly regimen of chemotherapy. A Hong Kong Tuberculosis Treatment Services-British Medical Research Council Investigation.
    Clin Allergy; 1974 Mar; 4(1):1-12. PubMed ID: 4824569
    [No Abstract]   [Full Text] [Related]  

  • 16. Side effects during intermittent rifampicin and ethambutol treatment. A preliminary report.
    Guerra Sanz FJ
    Scand J Respir Dis Suppl; 1973; 84():160-5. PubMed ID: 4522071
    [No Abstract]   [Full Text] [Related]  

  • 17. Side effects observed during intermittent rifampicin therapy.
    Stradling P
    Scand J Respir Dis Suppl; 1973; 84():129-31. PubMed ID: 4522066
    [No Abstract]   [Full Text] [Related]  

  • 18. [Recurrent renal failures in continuous treatment with rifampicin].
    Löllgen H; Bolte JP
    Munch Med Wochenschr; 1973 May; 115(20):913-5. PubMed ID: 4740450
    [No Abstract]   [Full Text] [Related]  

  • 19. Proceedings of the Workshop on Intermittent Drug Therapy and Immunological Implications in Antituberculous Treatment with Rifampicin. Oct. 2-3, 1972 Stockholm. Organized by The Department of Thoracic Medicine, Karolinska Sjukhuset.
    Scand J Respir Dis Suppl; 1973; 84():1-193. PubMed ID: 4593267
    [No Abstract]   [Full Text] [Related]  

  • 20. Controlled clinical evaluation of three intermittent regimens employing low-dosage schedules of rifampicin in original treatment of pulmonary tuberculosis. Preliminary data on effectiveness and side effects.
    Nitti V
    Scand J Respir Dis Suppl; 1973; 84():180-5. PubMed ID: 4593266
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.